Skip to content
Search

Latest Stories

MHRA drug alert for Ibuprofen 400 mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for Ibuprofen 400 mg tablets.

Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed the government agency that Patient Information Leaflet (PIL) within their packs of certain pharmacy (P) batches are incorrect.


The PIL in these batches includes incorrect dosing instructions in Section 3, How to take Ibuprofen. The leaflet incorrectly states that ‘The maximum daily dose should not exceed 6 [six] tablets (2400 mg)'.

The correct statement is: ‘The maximum daily dose should not be more than 3 tablets (1200 mg)'.

“This dosing regimen should only be given to patients who are under the supervision of their GP or healthcare prescriber and have been prescribed Ibuprofen 400mg Tablets. The outer carton contains the correct P indications and posology,” the MHRA statement read.

Pharmacists are asked to check the Marketing Authorisation Holder and the batch number while dispensing or providing the product over the counter and ensure that patients are aware of the correct dosage instructions and maximum daily dose as stated on the carton labelling.

MHRA further suggested to dispense these batches against a prescription rather than sold over the counter to safeguard patients from taking a prescription-only dose.

Product details:

Crescent Pharma Ltd

Ibuprofen 400mg Tablets (Almus Livery) PL 20416/0089

Batch NumberExpiry DatePack SizeFirst Distributed
DO3210N, DO3410N, DO3510N09.20228411 Jun 19
DO3310N 09.20228407 Aug 19
DO3610N10.20228418 Jul 19
DO3710N, DO3811N10.20228412 Mar 19
DO3911N10.20228419 Jul 19
DO4212N11.20228419 Jul 19
DO3110N09.20228416 Apr 19
DO1303N02.20228408 Oct 18
DO1003N02.20228412 Jul 18
DO0902N02.20228412 Jul 18

Ibuprofen 400mg Tablets (Crescent Livery) PL 20416/0089

Batch NumberExpiry DatePack SizeFirst Distributed
001205M04.20218408 Aug 19
DO0101O12.20228410 Jan 20
DO0503O02.20238410 Jan 20
DO4312N12.20228425 Nov 2019
DO3010N09.20228411 Dec 2019
DO1705O04.20238407 Oct 2019
DO1605O 04.20238418 Oct 2019
DO1505O 04.20238401 Oct 2019
DO1405O 04.20238401 Oct 2019
DO1305O 04.20238427 Dec 2019
DO1205O 04.20238409 Sep 2019
DO1104O 04.20238427 Dec 2019
DO1004O 03.20238409 Sep 2019
DO0904O03.20238421 Nov 2019
DO0804O03.20238421 Nov 2019
DO0703O03.20238415 Nov 2019
DO0603O02.20238415 Nov 2019
DO0403O02.20238415 Nov 2019

Flamingo Pharma (UK) Ltd

Ibuprofen 400mg Tablets (Flamingo Pharma Livery) PL 43461/0005

Batch NumberExpiry DatePack SizeFirst Distributed
1402177Aug-2324Oct-18
1402268Sep-2348Nov-18
1402278Oct-2324Dec-18
1402308, 1402309, 1402310Nov-2384Dec-18
1402316, 1402317Nov-2384Jan-19
1402318Dec-2324Jan-19
1402337, 1402338Dec-2348Jan-19
1402363, 1402353, 1402354Dec-2348Mar-19
1402352, 1402361, 1402362Dec-2384Mar-19
1402368Jan-2448Mar-19
1402369,1402370Jan-2424Mar-19
1402424Mar-2424Apr-19
1402425Mar-2348Apr-19
1402543, 1402544Mar-2448Jul-19
1402554Jun-2424Jul-19
1402557Jun-2484Aug-19
1402558, 1402559Jun-2448Aug-19
1402622, 1402623Jul-2448Sep-19
1402624, 1402625, 1402628Jul-2424Sep-19
1402670, 1402671, 1402672, 1402673Aug-2424Nov-19
1402674, 1402686, 1402687, 1402688, 1402705Sep-2448Nov-19
1402706Sep-2484Nov-19
1402707, 1402708Oct-2448Dec-19
1402709, 1402710Oct-2484Dec-19
1402711Nov-2484Jan-20
1402837, 1402838Dec-2424Feb-20
1402854Dec-2448Feb-20
1402839, 1402852Dec-2496Feb-20
1402853Dec-2484Feb-20

Ibuprofen 400mg Tablets (TEVA Livery) PL 43461/0005

Batch NumberExpiry DatePack SizeFirst Distributed
1402172, 1402173Jul-2384Sep-18
1402174, 1402175, 1402176, 1402178Aug-2384Oct-18
1402279Nov-2384Dec-18

More For You

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less
Community Pharmacies advised to reduce opening hours and services

Community Pharmacies advised to reduce opening hours and services

Breaking news: Pharmacies advised to reduce opening hours and services from April 1st

The government has been warned that community pharmacies will take collective action and reduce opening hours and services from April 1st unless there is an imminent clarity on a new funding contract.

The National Pharmacy Association (NPA) on Tuesday (17) announced that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

Keep ReadingShow less
More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less